Literature DB >> 23261225

[Extreme leucocytosis can lead to an erroneous diagnosis of severe hypoxaemia. Description of a case].

C Rodríguez1, S Pacreu2, N Baldomà1, S Sánchez1, E Vilà1, A Mases1.   

Abstract

The diagnosis and treatment of respiratory failure is a part of the anaesthesist's daily practice, as well as the hypoxaemia that is one of its physiological and analytical consequences. Patients with an extreme leucocytosis secondary to leukaemia can suffer an incorrect diagnosis of hypoxemia, called "pseudohypoxaemia". This is basically due to the rapid in vitro oxygen consumption, and is characterized by a low partial pressure of oxygen in arterial blood (PaO2) despite a normal oxygen saturation (SpO2) measured by pulse oximetry. Pseudohypoxaemia appears in patients with thrombocytosis or hyper-leucocytosis occurring during blastic crisis of a leukaemia. It must be suspected in patients with a discrepancy between the SpO2 measured by oximetry and the PaO2. In this context, pulse oximetry is the most accurate way to establish the diagnosis and to avoid unnecessary actions. We report the case of a patient with chronic myeloid leukaemia and extreme leucocytosis requiring emergency surgery, and diagnosed with pseudohypoxaemia during the perioperative period that led to a delay in the extubation of the patient.
Copyright © 2012 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Hiperleucocitosis; Hyperleucocytosis; Partial pressure of oxygen in arterial blood; Presión arterial de oxígeno; Pseudohypoxaemia; Pulse oximetry; Pulsioximetría; Seudohipoxemia

Mesh:

Substances:

Year:  2012        PMID: 23261225     DOI: 10.1016/j.redar.2012.10.013

Source DB:  PubMed          Journal:  Rev Esp Anestesiol Reanim        ISSN: 0034-9356


  1 in total

1.  Leukocytosis interference in clinical chemistry: Shall we still interpret test results without hematological data?

Authors:  Guillaume Grzych; Estelle Roland; David Beauvais; Patrice Maboudou; Giuseppe Lippi
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.